Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of ac… Read more
Market Cap & Net Worth: Sandoz Group AG (SDZXF)
Sandoz Group AG (OTCQX:SDZXF) has a market capitalization of $17.89 Billion ($17.89 Billion) as of March 18, 2026. Listed on the OTCQX stock exchange, this USA-based company holds position #1124 globally and #868 in its home market, demonstrating a -1.20% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sandoz Group AG's stock price $41.36 by its total outstanding shares 432692617 (432.69 Million).
Sandoz Group AG Market Cap History: 2023 to 2025
Sandoz Group AG's market capitalization history from 2023 to 2025. Data shows growth from $13.82 Billion to $17.89 Billion (0.00% CAGR).
Sandoz Group AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sandoz Group AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.60x
Sandoz Group AG's market cap is 1.60 times its annual revenue
1.01x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
19.58x
Sandoz Group AG's market cap is 19.58 times its annual earnings
10.29x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $13.82 Billion | $9.98 Billion | $77.00 Million | 1.38x | 179.47x |
| 2025 | $17.89 Billion | $11.16 Billion | $914.00 Million | 1.60x | 19.58x |
Competitor Companies of SDZXF by Market Capitalization
Companies near Sandoz Group AG in the global market cap rankings as of March 18, 2026.
Key companies related to Sandoz Group AG by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- MERCK Kommanditgesellschaft auf Aktien (PINK:MKGAF): Ranked #1164 globally with a market cap of $16.25 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #1164 | MERCK Kommanditgesellschaft auf Aktien | PINK:MKGAF | $16.25 Billion | $125.45 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
Sandoz Group AG Historical Marketcap From 2023 to 2025
Between 2023 and today, Sandoz Group AG's market cap moved from $13.82 Billion to $ 17.89 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $17.89 Billion | -8.81% |
| 2024 | $19.62 Billion | +42.00% |
| 2023 | $13.82 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Sandoz Group AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.89 Billion USD |
| MoneyControl | $17.89 Billion USD |
| MarketWatch | $17.89 Billion USD |
| marketcap.company | $17.89 Billion USD |
| Reuters | $17.89 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.